argenx SE (NAS:ARGX)
$ 376.96 20.95 (5.88%) Market Cap: 21.22 Bil Enterprise Value: 18.06 Bil PE Ratio: 0 PB Ratio: 5.52 GF Score: 74/100

Q1 2020 argenx SE Earnings and Business Update Call Transcript

May 14, 2020 / 01:00PM GMT
Release Date Price: $148.39 (+0.02%)
Operator

Welcome to the argenx First Quarter 2020 Financial Results and Business Update Conference Call. (Operator Instructions) To follow the presentation, we ask that you navigate the slides as directed by the argenx management. (Operator Instructions)

I would now like to introduce Beth DelGiacco, Vice President of Investor Relations of argenx.

Beth DelGiacco
argenx SE - VP of IR

Thank you. A press release with our first quarter 2020 business update and financial results was issued earlier today and can be found on our website, along with the presentation for today's webcast. I'm joined on the call today by Tim Van Hauwermeiren, Chief Executive Officer; Keith Woods, Chief Operating Officer; and Eric Castaldi, Chief Financial Officer.

Before we begin, I'd like to remind you on Slide 2 that forward-looking statements may be presented during this call. These may include statements about our future expectations, clinical development, regulatory time lines, the potential success of our product candidates, financial projections and upcoming milestones.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot